Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia (Q43955484)

28 November 2017

Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia (English)

1 reference

28 November 2017

1 reference

2

1 reference

28 November 2017

4

Anders Hamsten

1 reference

28 November 2017

1

Susanna Boquist

1 reference

28 November 2017

Karin Danell-Toverud

3

1 reference

PubMed ID

11947910

28 November 2017

language of work or name

1 reference

1 May 2002

1 reference

28 November 2017

1 reference

28 November 2017

162

1 reference

28 November 2017

163-170

1 reference

28 November 2017

1

1 reference

Postprandial lipoprotein metabolism and atherosclerosis.

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Echolucent carotid artery plaques are associated with elevated levels of fasting and postprandial triglyceride-rich lipoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Postprandial lipemia, fenofibrate and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Post-prandial metabolism of triglyceride-rich lipoproteins in non-insulin-dependent diabetic patients before and after bezafibrate treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Fenofibrate improves postprandial chylomicron clearance in II B hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Apolipoprotein E*3-Leiden allele results from a partial gene duplication in exon 4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Metabolism of triglyceride-rich lipoproteins during alimentary lipemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

The hemostatic system and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Effect of a single high-fat meal on endothelial function in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Governance of the concentration of plasma LDL: a reevaluation of the LDL receptor paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Lowering effects of four different statins on serum triglyceride level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Comparison of statins in hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

The role of the LDL receptor in apolipoprotein B secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Postprandial vitamin A and squalene clearances and cholesterol synthesis off and on lovastatin treatment in type III hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Effects of pravastatin with niacin or magnesium on lipid levels and postprandial lipemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Modulation of chylomicron remnant metabolism by an hepatic hydroxymethylglutaryl coenzyme A reductase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

Lipoprotein fractionation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900689-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(01)00689-X

1 reference

28 November 2017

1 reference

PubMed ID

11947910